<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04088617</url>
  </required_header>
  <id_info>
    <org_study_id>H16-01846-B</org_study_id>
    <nct_id>NCT04088617</nct_id>
  </id_info>
  <brief_title>The Effects of Exogenous Ketones on Glucose Tolerance</brief_title>
  <official_title>The Effects of Exogenous Ketones on Glucose Tolerance</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of British Columbia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of British Columbia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The ketone body beta-hydroxybutyrate is produced during prolonged fasting or when endogenous
      carbohydrate stores are depleted and can be used as an alternative fuel source. Exogenous
      beta-hydroxybutyrate, in the form of a ketone monoester, is proposed to have glucose-lowering
      potential but this has not been adequately studied. The purpose of this study is to determine
      whether supplementing with an acute dose of ketone monoester can improve the glycemic
      response to a high carbohydrate mixed meal in young healthy individuals.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 1, 2019</start_date>
  <completion_date type="Actual">January 5, 2020</completion_date>
  <primary_completion_date type="Actual">October 30, 2019</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>Crossover assignment</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
    <masking_description>Placebo masked with flavouring and participants consume in opaque containers</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Glucose area under the curve</measure>
    <time_frame>2-hour</time_frame>
    <description>Area under the curve for glucose during high carbohydrate mixed meal tolerance test</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Insulin area under the curve</measure>
    <time_frame>2-hour</time_frame>
    <description>Insulin area under the curve during high carbohydrate mixed meal tolerance test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Free fatty acids area under the curve</measure>
    <time_frame>2-hour</time_frame>
    <description>Non-esterified fatty acids area under the curve during high carbohydrate mixed meal tolerance test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glucose incremental area under the curve</measure>
    <time_frame>2-hour</time_frame>
    <description>Incremental area under the curve (above baseline) for glucose during high carbohydrate mixed meal tolerance test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Insulin incremental area under the curve</measure>
    <time_frame>2-hour</time_frame>
    <description>Incremental area under the curve (above baseline) for insulin during high carbohydrate mixed meal tolerance test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>2-hr glucose level</measure>
    <time_frame>2-hour</time_frame>
    <description>Plasma glucose assessed 2-hr after high carbohydrate mixed meal tolerance test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Beta-hydroxybutyrate level</measure>
    <time_frame>2-hour</time_frame>
    <description>Blood beta-hydroxybutyrate concentration assessed by handheld monitor</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Dietary Supplement: Ketone Supplement</condition>
  <condition>Dietary Supplement: Placebo</condition>
  <arm_group>
    <arm_group_label>Ketone monoester</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Acute morning dose of (R)-3-hydroxybutyl (R)-3-hydroxybutyrate (0.45 ml/kg body weight)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Acute morning dose of flavour-matched placebo.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Ketone monoester</intervention_name>
    <description>Acute ingestion of (R)-3-hydroxybutyl (R)-3-hydroxybutyrate prior a 2-hour high carbohydrate mixed meal tolerance test.</description>
    <arm_group_label>Ketone monoester</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Acute ingestion of a taste-matched placebo prior a 2-hour high carbohydrate mixed meal tolerance test.</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Young healthy individuals

          -  Not taking any medications affecting glucose metabolism

        Exclusion Criteria:

          -  Competitive endurance athlete (i.e., train specifically for cycling, triathlon or
             distance running and compete at a high level)

          -  Diagnosed with the chronic medical condition that may impact consumption of
             carbohydrates or supplements (e.g., diabetes, heart disease)

          -  Are currently using medications that may interfere with insulin sensitivity

          -  Adhere to a strict high-fat low-carbohydrate or ketogenic diet (within the last 3
             months)

          -  Are currently using ketone supplements

          -  Unable to travel to and from the university in order to make your testing
             appointments.

          -  Unable to follow the controlled diet instructions required for the study.

          -  If pregnant or are planning to become pregnant during the study (if female)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of British Columbia, Okanagan</name>
      <address>
        <city>Kelowna</city>
        <state>British Columbia</state>
        <zip>V1V 1V7</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>September 11, 2019</study_first_submitted>
  <study_first_submitted_qc>September 11, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 13, 2019</study_first_posted>
  <last_update_submitted>March 23, 2020</last_update_submitted>
  <last_update_submitted_qc>March 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 24, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of British Columbia</investigator_affiliation>
    <investigator_full_name>Jonathan Little</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

